Search Results - "ISRAËL, Maurice"

Refine Results
  1. 1

    l-arginine improves dystrophic phenotype in mdx mice by Voisin, Vincent, Sébrié, Catherine, Matecki, Stéfan, Yu, Hua, Gillet, Brigitte, Ramonatxo, Michèle, Israël, Maurice, De la Porte, Sabine

    Published in Neurobiology of disease (01-10-2005)
    “…A possible treatment for Duchenne muscular dystrophies would be to compensate for dystrophin loss by increasing the expression of utrophin, another…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The metabolic advantage of tumor cells by Israël, Maurice, Schwartz, Laurent

    Published in Molecular cancer (07-06-2011)
    “…1- Oncogenes express proteins of "Tyrosine kinase receptor pathways", a receptor family including insulin or IGF-Growth Hormone receptors. Other oncogenes…”
    Get full text
    Journal Article
  4. 4

    An alteration of the endocrine pancreas involved in cancer by Israël, Maurice

    Published in Cancer causes & control (01-12-2014)
    “…Tumor cells display hybrid metabolic features: some of their enzymes are phosphorylated as normally observed when catabolic hormones stimulate Gs-coupled…”
    Get full text
    Journal Article
  5. 5

    Cancer Metabolism: Fasting Reset, the Keto-Paradox and Drugs for Undoing by Israël, Maurice, Berg, Eric, Tenenbaum, Guy

    Published in Journal of clinical medicine (17-02-2023)
    “…In tumor cells, ketolysis "via" succinyl-CoA: 3-oxoacid-CoAtransferase (SCOT) and acetyl-CoA acetyltransferase 1 (ACAT1) is a major source of mitochondrial…”
    Get full text
    Journal Article
  6. 6

    Increase in External Glutamate and NMDA Receptor Activation Contribute to H2O2‐Induced Neuronal Apoptosis by Mailly, Franck, Marin, Philippe, Israël, Maurice, Glowinski, Jacques, Prémont, Joël

    Published in Journal of neurochemistry (01-09-1999)
    “…: The present study aims to investigate the role of extracellular glutamate and NMDA receptor stimulation in the neuronal death induced by a transient exposure…”
    Get full text
    Journal Article
  7. 7

    A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas by Israël, Maurice

    Published in Molecular cancer (06-09-2012)
    “…Cancer is a devastating type of disease. New and innovative ways to tackle cancers that have so far proved refractive to conventional therapies is urgently…”
    Get full text
    Journal Article
  8. 8

    Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy by Chaubourt, E, Fossier, P, Baux, G, Leprince, C, Israël, M, De La Porte, S

    Published in Neurobiology of disease (01-12-1999)
    “…Duchenne muscular dystrophy (DMD), a severe X-linked recessive disorder which results in progressive muscle degeneration, is due to a lack of dystrophin, a…”
    Get full text
    Journal Article
  9. 9

    Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models by Vianello, Sara, Consolaro, Francesca, Bich, Claudia, Cancela, José‐Manuel, Roulot, Morgane, Lanchec, Erwan, Touboul, David, Brunelle, Alain, Israël, Maurice, Benoit, Evelyne, Porte, Sabine

    Published in The FASEB journal (01-06-2014)
    “…ABSTRACT A new approach to treating Duchenne muscular dystrophy was investigated by using the ester or amide covalent association of arginine [nitric oxide…”
    Get full text
    Journal Article
  10. 10

    Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin by Schwartz, Laurent, Guais, Adeline, Israël, Maurice, Junod, Bernard, Steyaert, Jean-Marc, Crespi, Elisabetta, Baronzio, Gianfranco, Abolhassani, Mohammad

    Published in Investigational new drugs (01-04-2013)
    “…Summary Cellular metabolic alterations are now well described as implicated in cancer and some strategies are currently developed to target these different…”
    Get full text
    Journal Article
  11. 11

    Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy by Vianello, Sara, Yu, Hua, Voisin, Vincent, Haddad, Hafedh, He, Xun, Foutz, Arthur S., Sebrié, Catherine, Gillet, Brigitte, Roulot, Morgane, Fougerousse, Françoise, Perronnet, Caroline, Vaillend, Cyrille, Matecki, Stefan, Escolar, Diana, Bossi, Laura, Israël, Maurice, Porte, Sabine

    Published in The FASEB journal (01-06-2013)
    “…As a strategy to treat Duchenne muscular dystrophy, we used arginine butyrate, which combines two pharmacological activities: nitric oxide pathway activation,…”
    Get full text
    Journal Article
  12. 12

    A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: Preliminary results by SCHWARTZ, Laurent, ABOLHASSANI, Mohammad, GUAIS, Adeline, SANDERS, Edward, STEYAERT, Jean-Marc, CAMPION, Frederic, ISRAËL, Maurice

    Published in Oncology reports (01-05-2010)
    “…The impact of metabolic dysregulation on tumor development has long been established. We have targeted two enzymes that are altered during carcinogenesis:…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Acetylcholine release and the cholinergic genomic locus by Israël, M, Dunant, Y

    Published in Molecular neurobiology (01-02-1998)
    “…Choline acetyltransferase and vesicular acetylcholine-transporter genes are adjacent and coregulated. They define a cholinergic locus that can be turned on…”
    Get full text
    Journal Article
  16. 16

    Acetylcholine synthesis and quantal release reconstituted by transfection of mediatophore and choline acetyltranferase cDNAs by Bloc, Alain, Bugnard, Elisabeth, Dunant, Yves, Falk-Vairant, Jean, Israël, Maurice, Loctin, Françoise, Roulet, Emmanuelle

    Published in The European journal of neuroscience (01-05-1999)
    “…Neuroblastoma N18TG‐2 cells cannot synthesize or release acetylcholine (ACh), and do not express proteins involved in transmitter storage and vesicle fusion…”
    Get full text
    Journal Article
  17. 17

    Effect of brefeldin A on acetylcholine release from glioma C6BU-1 cells by Malo, Michel, Vurpillot, Cédric, Tomasi, Monique, Bruner, Jan, Stinnakre, Jacques, Israël, Maurice

    Published in Neuropharmacology (01-10-2000)
    “…The glial C6BU-1 cell line, loaded with acetylcholine can release this neurotransmitter. This study was aimed at determining whether disruption of the…”
    Get full text
    Journal Article
  18. 18

    Continuous determination by a chemiluminescent method of acetylcholine release and compartmentation in Torpedo electric organ synaptosomes by Israël, M, Lesbats, B

    Published in Journal of neurochemistry (01-12-1981)
    “…The detection of acetylcholine (ACh) with a chemiluminescent procedure enables one to follow continuously the release of transmitter from stimulated…”
    Get more information
    Journal Article
  19. 19

    Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity by Maus, Marion, Marin, Philippe, Israël, Maurice, Glowinski, Jacques, Prémont, Joël

    Published in The European journal of neuroscience (01-09-1999)
    “…A sustained release of glutamate contributes to neuronal loss during cerebral ischaemia. Using cultured mouse striatal neurons, we observed that glucose…”
    Get full text
    Journal Article
  20. 20

    Application to mammalian tissues of the chemiluminescent method for detecting acetylcholine by Israël, M, Lesbats, B

    Published in Journal of neurochemistry (01-07-1982)
    “…It is now possible to extend to mammalian tissues the chemiluminescent acetylcholine assay. Mammalian tissue extracts must be treated with oxidants (which is…”
    Get more information
    Journal Article